Skip to main content
Clinical Trials/NCT06085261
NCT06085261
Not Yet Recruiting
N/A

Chronic Obstructive Pulmonary Disease: A Multi-center Supervised Tele-rehabilitation Study

China-Japan Friendship Hospital1 site in 1 country360 target enrollmentNovember 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
China-Japan Friendship Hospital
Enrollment
360
Locations
1
Primary Endpoint
6-minute walk distance (6MWD)
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Chronic obstructive pulmonary disease(COPD) patients could benefit from pulmonary rehabilitation(PR) in better managing of the disease and its symptoms and in avoiding future relapses and hospitalizations. However, due to a large number of drop outs from PR, lack of professionals, and the (Corona Virus Disease 2019) COVID-19 epidemic, the PR has been underutilized, leading to a need for investigation of updated forms. The study aims to investigate the effects of a home-based PR program using minimal accessories, facilitated with wearable activity trackers and smartphones.

Registry
clinicaltrials.gov
Start Date
November 2023
End Date
December 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
China-Japan Friendship Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ting YANG

Principal Investigator, Clinical Professor

China-Japan Friendship Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Certain comorbidities (e.g. unstable coronary complications)
  • Severe cognitive disabilities (e.g. dementia)
  • Inability to cope with the program because of severe hearing or visual disorder.

Outcomes

Primary Outcomes

6-minute walk distance (6MWD)

Time Frame: 8 weeks; 20 weeks

6-minute walk distance

Secondary Outcomes

  • St. George's Respiratory Questionnaire (SGRQ)(8 weeks; 20 weeks)
  • Hospital Anxiety and Depression Scale(HADS)(8 weeks; 20 weeks)
  • pulmonary function(8 weeks; 20 weeks)
  • Short Physical Performance Battery(SPPB)(8 weeks; 20 weeks)
  • COPD assessment test(CAT)(8 weeks; 20 weeks)
  • modified British medical research council(mMRC)(8 weeks; 20 weeks)
  • Respiratory muscle strength(8 weeks; 20 weeks)

Study Sites (1)

Loading locations...

Similar Trials